Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
2,829 total articles
Urban Outfitters (URBN) trades at attractive multiples (P/E ~11.2, P/S ~0.92, EV/EBITDA ~7.5) while delivering high-margin subscription growth and consistent free cash flow. With no net debt, an ROE near 18%, and recent earnings beats, I see a mid-term swing trade to capture multiple expansion and seasonal strength — entry $61.20, target $78.00, st…
Nvidia's dominance in AI compute is showing up in hard financials: strong free cash flow, high returns on capital, and a still-deep moat around data-center GPUs. Valuation is rich but not irrational for a company generating nearly $97B of FCF and commanding a ~$4.1T market cap. This trade idea buys a controlled dip at current levels for a long-term…
Amalgamated Financial (AMAL) looks priced for downside by some analysts, but the bank's earnings power, low leverage and rising dividends argue against an immediate downgrade. We'll outline a long trade with a defined entry at $38.00, a stop at $35.50 and a target at $42.65, framed for a 120-trading-day horizon.
Nebius (NBIS) is trading off a recent rally despite securing massive hyperscaler contracts and aggressively ramping GPU capacity. The setup favors a disciplined long: entry at $101, stop at $92, target $150. Balance the upside from a $49B contracted backlog and a $7-9B ARR pathway against execution, capital intensity, and short-volume pressure.
MongoDB shares have been hit hard after softer guidance, leaving the stock trading at roughly $18.9B market cap with strong free cash flow and an oversold technical setup. We upgrade to Buy and recommend a mid-term dip-buy: entry $235.40, target $320.00, stop $200.00. Catalysts include Atlas reacceleration, margin leverage and macro stabilization; …
Newmont (NEM) is not the most explosive lever to gold, but it is the most dependable. With $7.3B of free cash flow in 2025, a conservative capital structure (debt/equity ~0.15), and valuation metrics that look reasonable for a defensible producer, I recommend a tactical long: entry $102.21, stop $94.00, target $125.00 over a mid term (45 trading da…
BDRFF has plunged into deeply oversold territory while short interest and short-volume spikes suggest a crowded trade. The setup favors a disciplined long: enter at $84.00, protect at $74.00, and target $100.00 over a 180-trading-day horizon, seeking mean reversion to the 50-day band and potential short-covering relief.
Synopsys (SNPS) slid to the mid-$300s on headline-driven selling, but the business remains cash-generative with favorable secular exposure to semiconductor design, IP security, and AI-enabled workflows. Reports of an Elliott stake confirm outside investor interest; we view the pullback as a tactical entry for a mid-term trade toward $480 while pres…
PepsiCo is a blue-chip income compounder trading at ~$153 with a 3.7% yield, $7.7B in free cash flow and valuation that leaves room for upside if corporate actions accelerate. Add in market chatter about activist engagement and a sub-160 technical setup, and you get a tactical, defensive long with defined risk control.
New Mountain Finance (NMFC) yields ~17% and trades at just 0.64x book value while focusing on senior-secured loans to upper-middle-market companies. The combination of a large cash dividend, subdued technicals and low relative short interest creates a tactical long opportunity with defined risk controls.
GitLab (GTLB) trades at roughly 3.6x price-to-sales with $222M of trailing free cash flow, a $3.46B market cap, and an oversold technical setup. Recent guidance cut and early-stage AI platform concerns have left the stock beaten down, creating a defined-risk long opportunity for a long-term holding period (180 trading days). Entry at current levels…
Fabrinet (FN) is executing well: double-digit revenue growth, improving margins and cash flow, low leverage and meaningful buyback activity. Those fundamentals have pushed the stock to a premium multiple and near its 52-week highs. For traders looking to capitalize on valuation compression or a cyclical slowdown in optical demand, a disciplined sho…
POET Technologies offers a differentiated optical interposer approach that addresses the industry bottleneck around specialized lasers. Recent partnerships, prototype timelines and a sizable market-capital raise set up a clear mid-term trade. Enter near $5.20, stop at $4.10, target $7.50 for a swing play over the next 45 trading days, with upside t…
Innovative Solutions & Support (ISSC) is a micro-cap avionics supplier that just went through a painful integration and short-term margin cycle after acquiring an F-16 product line from Honeywell. Revenue growth has already re-rated the stock — Q3 2025 sales jumped 105% to $24.1M — and the business now trades at roughly $382M market cap with health…
Global Business Travel (GBTG) trades at $5.33 with a $2.79B market cap. Recent volume and institutional interest, improving free cash flow ($104M) and an addressable bleisure/business travel market backdrop argue for upside to $9.00 over the next 180 trading days. Enter $5.30, stop $4.95, target $9.00. Risk/reward is favorable but keep an eye on ex…
Wintrust (WTFC) is a well-run regional bank with healthy profitability, a growing dividend and reasonable valuation. Recent pullback leaves an asymmetric, controlled-risk swing trade: enter on the current weakness, target a return-to-trend level near $150, and use a clear stop to protect against macro-driven credit or margin deterioration.
Argan (AGX) is trading at 52-week highs after a blowout quarter and a $2.9B+ backlog. Valuation is rich, but a cash-rich, no-debt balance sheet and strong free cash flow support a mid-term long trade. Entry, stop and target provided with clear catalysts and risk management.
JD.com trades at a $45.4B market cap with a P/E of 15.6, a P/B of 1.33 and a 3.4% dividend yield. Even if top-line growth slows, the combination of low valuation, a capital-light distribution network, improving technicals, and an upcoming dividend payment make JD an actionable long trade with defined stop and target levels.
Seagate is benefiting from accelerating AI data-center demand, with recent results showing 22% revenue growth, a 42.2% gross margin and heavy free-cash generation. The stock trades at a premium multiple, but operational leverage, multi-year order visibility and improving margins make a long trade attractive with disciplined stops.
Fastly is benefiting from surging AI-related edge traffic and just reported strong Q4 results. The balance sheet and improving cash flow give a cleaner runway, but a 6.7x price-to-sales multiple and lingering GAAP losses mean you should trade with a plan. This idea lays out a buy entry, clear stop, and realistic targets across a 45-trading-day swin…
CAVA's plan to scale to 1,000 restaurants by 2032, combined with rising revenue and solid operating leverage, gives the stock a fundamental runway that supports a long trade. Valuation is rich on earnings multiples but defensible when you view the business as a fast-growing platform with CPG upside and no corporate debt. We lay out an actionable en…
Micron's role as a primary supplier of HBM4 and high-density DRAM places it at the center of the AI infrastructure buildout. Recent operational data show blowout revenue growth and very healthy margins, but the memory business is cyclical and competition/custom silicon could compress returns. This trade targets a re-rating if AI demand stays struct…
Broadcom is a rare combination of durable software and semiconductor franchises, strong free cash flow and accelerating AI-related revenues. The stock looks reasonably priced for continued execution at current levels: the pullback has created a tactical entry around $301 with defined risk and an attractive mid-term upside if AI momentum holds.
Duolingo dropped on near-term guidance and a pivot to prioritize engagement via AI. That sell-off creates a low-risk entry for patient buyers: the business is cash-generative, cheap on current earnings, and has clear catalysts for re-rating if AI features expand ARPU and retention. Trade plan with entry at $95.37, stop at $85.00, target $140.00, ho…
Scholar Rock (SRRK) has endured a rocky regulatory and manufacturing path for its lead candidate apitegromab, but the market now discounts much of that uncertainty. With a market cap of roughly $4.9B, negative free cash flow of $300.6M and key catalysts lined up in 2026, we maintain a Buy and propose an actionable trade plan to capture approval and…
